Cardiac: Page 2

  • A person wearing scrubs, a mask and a cap looks at a screen with images.
    Image attribution tooltip
    Courtesy of Philips
    Image attribution tooltip

    Philips to acquire SpectraWAVE

    SpectraWAVE makes technologies to help diagnose and guide treatment decisions for coronary artery disease.

    By • Dec. 15, 2025
  • AtriCure’s EnCompass Clamp device is shown against a white background.
    Image attribution tooltip
    Retrieved from AtriCure on December 12, 2025
    Image attribution tooltip

    AtriCure treats first patients with dual PFA/RF system

    Combining pulsed field ablation and a radiofrequency technique in one platform is expected to reduce procedure times.

    By • Dec. 12, 2025
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendline➔
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • An anatomical heart is pictured in red in a transparent body.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Impulse Dynamics raises $158M to commercialize heart failure device

    By strengthening heart contractions, Impulse’s device could improve quality of life, restore functional capacity and enhance tolerance for exercise. 

    By • Dec. 11, 2025
  • A sign for the FDA is shown in front of the headquarters building in Silver Spring, Maryland.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    FDA pilots allowing digital health devices access to CMS payment program

    Companies can ask the FDA to waive premarket authorization and investigational device requirements while they collect real-world data in a CMS program.

    By • Dec. 10, 2025
  • V-Wave's implantable device for heart failure is shown next to a dime.
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip

    FDA advisory panel votes unanimously against J&J heart shunt

    Panelists focused on study data that showed the implant did not improve outcomes in heart failure patients.

    By • Dec. 5, 2025
  • A warehouse with rows of packages
    Image attribution tooltip
    Courtesy of Medline
    Image attribution tooltip

    PitchBook: AI tuck-in deals to drive M&A acceleration in 2026

    Buyers will focus on “tuck-ins that add AI or data-driven capabilities or can meaningfully improve scale against emerging competitors,” the analysts said.

    By • Dec. 3, 2025
  • Boston Scientific's Farawave pulsed field ablation catheter is shown against a white background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    CMS covers cardiac ablation in ambulatory surgery centers

    Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.

    By • Nov. 26, 2025
  • A 3D visualization of red blood cells traveling through a blood vessel.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Okami raises $45M to commercialize vascular embolization devices

    The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.

    By • Nov. 24, 2025
  • Nick West, chief medical officer of J&J unit Shockwave, smiles in a headshot.
    Image attribution tooltip
    Permission granted by J&J MedTech
    Image attribution tooltip
    Q&A

    Shockwave’s Nick West on shaking up treatment for blocked arteries

    The chief medical officer for the new J&J unit discussed intravascular lithotripsy’s rapid growth and what to expect from the pipeline in a conversation with MedTech Dive.

    By • Nov. 21, 2025
  • A physician in blue scrubs and a mask looks at Philips' DeviceGuide images on a large screen.
    Image attribution tooltip
    Courtesy of Philips
    Image attribution tooltip

    Philips, Edwards team on AI-based guide for mitral valve repair

    Artificial intelligence combines ultrasound and X-ray images to give physicians a real-time 3D view of the repair device during transcatheter heart procedures.

    By • Nov. 19, 2025
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic’s PFA business is heating up

    Pulsed field ablation sales grew by more than 300% in the second quarter for the company’s 2026 fiscal year, amid mounting competition in the space.

    By • Nov. 18, 2025
  • A rendering of a rounded device with a wire structure surrounded by mesh.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific, Siemens Healthineers partner on cardiac catheter

    Intended for use in structural heart procedures, the cardiac imaging catheter is expected to drive growth for Boston Scientific’s Watchman device.

    By • Nov. 17, 2025
  • Medtronic's Jason Fontana is wearing a blue suit and blue patterned tie in a headshot.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip
    Q&A

    Medtronic’s Jason Fontana on ramping up renal denervation

    The general manager for the business says building a market is something the medtech giant knows how to do.

    By • Nov. 5, 2025
  • A corporate building for Edwards Lifesciences.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards CFO Scott Ullem to exit post

    Ullem, who has held the position for more than a decade, will transition to an advisory role after his replacement is named by mid-2026.

    By • Oct. 31, 2025
  • Two clinicians view data showing the condition of a patient's arteries on a large screen.
    Image attribution tooltip
    Courtesy of Philips
    Image attribution tooltip

    3 takeaways from TCT 2025

    Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.

    By • Oct. 31, 2025
  • Rendering of a spiral-shaped catheter with four electrodes
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    CMS grants NCD for renal denervation, benefiting Medtronic, Recor

    National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained FDA approval in 2023.

    By • Oct. 29, 2025
  • A coil-shaped device is shown moving through a tube with branching structures around it.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic links renal denervation to 3-year blood pressure reduction

    Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment after three years.

    By • Oct. 28, 2025
  • The robot-enhanced heart valve replacement system is depicted in an illustration that includes a patient on a table.
    Image attribution tooltip
    Courtesy of CardioPrecision
    Image attribution tooltip
    Profile

    Corcym, CardioPrecision set sights on robotic heart valve replacement

    The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the longer-term advantages of open heart surgery.

    By • Oct. 27, 2025
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific continues to win in electrophysiology

    Strong sales growth in the company’s electrophysiology unit comes amid a market fight between some of the medtech industry’s largest players.

    By • Oct. 22, 2025
  • Person wears Oura ring in a car
    Image attribution tooltip
    Courtesy of Oura
    Image attribution tooltip

    Ōura to pursue FDA clearance of blood pressure feature for smart ring

    The company has received approval to validate and define the feature in a study that is scheduled to start this year.

    By • Oct. 20, 2025
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott CEO: ‘We’re right on time’ to the PFA party

    As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors that the company is not just playing defense.

    By • Oct. 15, 2025
  • An anatomical heart is pictured in red in a transparent body.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Stereotaxis teams with CardioFocus to develop robotic PFA system

    Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ablation.

    By • Oct. 15, 2025
  • illustration of a heart showing a tube-shaped device going into the left ventricle
    Image attribution tooltip
    Courtesy of Abiomed
    Image attribution tooltip

    Cybersecurity triggers another recall of J&J’s Impella heart pump controller

    While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious injury or death.

    By • Oct. 14, 2025
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic wins CE mark for Penditure LAA exclusion device

    The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.

    By • Oct. 3, 2025
  • Boston Scientific's Farapulse pulsed field ablation device.
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip

    Boston Scientific aims for market leadership in electrophysiology

    The company has now treated 500,000 patients with its pulsed field ablation system, in a competitive category poised for growth.

    By • Oct. 2, 2025